Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2009

01-12-2009 | Invited Commentary

Genomic analysis from tissue core biopsies: standard of care for the future?

Authors: Sudipa Sarkar, David P. Tuck, Lyndsay N. Harris

Published in: Breast Cancer Research and Treatment | Issue 3/2009

Login to get access

Excerpt

The article by Tebbit et al. provides an important contribution to the literature on standardizing the practice of collecting tissue core biopsies for genomic studies. As the trend in oncology treatment emphasizes personalized medicine, genomic studies are no longer of academic interest only but are poised to take on a central role in clinical decision-making. As such, quality standards for the methods by which biospecimens are processed become essential. …
Literature
1.
2.
Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L (1999) Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 44(5):1005–1015. doi:10.​1016/​S0360-3016(99)00112-1 PubMed
3.
Kerkhoven RM, Sie D, Nieuwland M, Heimerikx M, De Ronde J, Brugman W, Velds A (2008) The T7-primer is a source of experimental bias and introduces variability between microarray platforms. PLoS One 3(4):e1980CrossRefPubMed
4.
Lyng MB, Laenkholm A-V, Pallisgaard N, Vach W, Knoop A, Bak M, Ditzel HJ (2007) Intratumor genetic heterogeneity of breast carcinomas as determined by fine needle aspiration and TaqMan low density array. Cell Oncol 29:361–372PubMed
Metadata
Title
Genomic analysis from tissue core biopsies: standard of care for the future?
Authors
Sudipa Sarkar
David P. Tuck
Lyndsay N. Harris
Publication date
01-12-2009
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2009
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-009-0337-x

Other articles of this Issue 3/2009

Breast Cancer Research and Treatment 3/2009 Go to the issue

Clinical trial

Reporting of race and ethnicity in breast cancer research: room for improvement

Brief Report

Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERα

Clinical trial

Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users

Letter to the Editor

The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features

Preclinical Study

Opposite effects of protein kinase C beta1 (PKCβ1) and PKCε in the metastatic potential of a breast cancer murine model

Clinical trial

Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits